Clinical Trials Browser

Phase 1 × Advanced Solid Tumor × camrelizumab × Clear all

NCT03871855 2023-06-05

A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumor